First Manhattan CO Bridge Bio Pharma, Inc. Transaction History

First Manhattan CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $476,400 - $741,600	-60,000 Reduced 68.58%	27,490 $273,000
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $455,822 - $1.06 Million	87,490 New	87,490 $794,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $4,552 - $21,364	-400 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $22,188 - $28,939	400 New	400 $24,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.08B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.